Hans Walter Lindemann

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post et al. · The Lancet Oncology · 2012 · 507 citations

Medicine, Oncology, Chemotherapy +12

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML

Alice Fabarius, Lida Kalmanti, Christian Dietz et al. · Annals of Hematology · 2015 · 79 citations

Life Sciences, Genetics, Hematology +8

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

Hartmut Goldschmidt, Marc‐Andrea Baertsch, Jana Schlenzka et al. · Leukemia · 2020 · 67 citations

Medicine, Oncology, Pharmacotherapy +15

Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial

Pieter Sonneveld, Hans-Juergen Salwender, Bronno van der Holt et al. · Blood · 2015 · 38 citations

Medicine, Hematology, Pharmacotherapy +17

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

Jan Braess, Susanne Amler, Karl‐Anton Kreuzer et al. · Leukemia · 2018 · 32 citations · Full text

Medicine, Oncology, Pharmacology +13